Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Rhodium(II)-catalyzed enantioselective C-H functionalization of indoles.
J Am Chem Soc. 2011 Feb 16;133(6):1650-3. doi: 10.1021/ja1093309. Epub 2011 Jan 25.
J Am Chem Soc. 2011.
PMID: 21265565
Free PMC article.
A general and enantioselective approach to pentoses: a rapid synthesis of PSI-6130, the nucleoside core of sofosbuvir.
Peifer M, Berger R, Shurtleff VW, Conrad JC, MacMillan DW.
Peifer M, et al. Among authors: shurtleff vw.
J Am Chem Soc. 2014 Apr 23;136(16):5900-3. doi: 10.1021/ja502205q. Epub 2014 Apr 9.
J Am Chem Soc. 2014.
PMID: 24670208
Free PMC article.
Item in Clipboard
Switching on elusive organometallic mechanisms with photoredox catalysis.
Terrett JA, Cuthbertson JD, Shurtleff VW, MacMillan DW.
Terrett JA, et al. Among authors: shurtleff vw.
Nature. 2015 Aug 20;524(7565):330-4. doi: 10.1038/nature14875. Epub 2015 Aug 12.
Nature. 2015.
PMID: 26266976
Free PMC article.
Item in Clipboard
Native functionality in triple catalytic cross-coupling: sp³ C-H bonds as latent nucleophiles.
Shaw MH, Shurtleff VW, Terrett JA, Cuthbertson JD, MacMillan DW.
Shaw MH, et al. Among authors: shurtleff vw.
Science. 2016 Jun 10;352(6291):1304-8. doi: 10.1126/science.aaf6635. Epub 2016 Apr 28.
Science. 2016.
PMID: 27127237
Free PMC article.
Item in Clipboard
Synthesis of C6-Substituted Purine Nucleoside Analogues via Late-Stage Photoredox/Nickel Dual Catalytic Cross-Coupling.
Perkins JJ, Shurtleff VW, Johnson AM, El Marrouni A.
Perkins JJ, et al. Among authors: shurtleff vw.
ACS Med Chem Lett. 2021 Mar 8;12(4):662-666. doi: 10.1021/acsmedchemlett.0c00673. eCollection 2021 Apr 8.
ACS Med Chem Lett. 2021.
PMID: 33859805
Free PMC article.
Item in Clipboard
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic.
Shurtleff VW, Layton ME, Parish CA, Perkins JJ, Schreier JD, Wang Y, Adam GC, Alvarez N, Bahmanjah S, Bahnck-Teets CM, Boyce CW, Burlein C, Cabalu TD, Campbell BT, Carroll SS, Chang W, de Lera Ruiz M, Dolgov E, Fay JF, Fox NG, Goh SL, Hartingh TJ, Hurzy DM, Kelly MJ 3rd, Klein DJ, Klingler FM, Krishnamurthy H, Kudalkar S, Mayhood TW, McKenna PM, Murray EM, Nahas D, Nawrat CC, Park S, Qian D, Roecker AJ, Sharma V, Shipe WD, Su J, Taggart RV, Truong Q, Wu Y, Zhou X, Zhuang N, Perlin DS, Olsen DB, Howe JA, McCauley JA.
Shurtleff VW, et al.
J Med Chem. 2024 Mar 14;67(5):3935-3958. doi: 10.1021/acs.jmedchem.3c02248. Epub 2024 Feb 16.
J Med Chem. 2024.
PMID: 38365209
Item in Clipboard
Cite
Cite